Stock Events

Stock Events

AEON Biopharma 

$0.99
0
+$0.02+2.07% Wednesday 02:10

Statistics

Day High
0.99
Day Low
0.99
52W High
-
52W Low
-
Volume
4,536
Avg. Volume
-
Mkt Cap
11.66M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q3 2025
Next
Next
-0.43
-0.36
-0.28
-0.21
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2020
2021
2022
2023
2024
0Revenue
84.01MNet Income

Analyst Ratings

$7.20Average Price Target
The highest estimate is 7.20.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AEON.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evolus
EOLS
Mkt Cap417.87M
Evolus directly competes with AEON Biopharma in the aesthetic and therapeutic botulinum toxin products sector.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, competes in the botulinum toxin market, particularly in therapeutic areas.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. competes in the broader pharmaceuticals market, including areas that overlap with AEON Biopharma's focus.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes in the pharmaceuticals sector, including development of products that could compete with AEON Biopharma's offerings.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb competes in the pharmaceutical industry, potentially overlapping with AEON Biopharma's therapeutic areas.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, including areas relevant to AEON Biopharma's market.
Novartis
NVS
Mkt Cap237.61B
Novartis competes in the global healthcare market, including in therapeutic areas that may overlap with AEON Biopharma's focus.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes across the healthcare spectrum, including pharmaceuticals that could compete with AEON Biopharma's products.

About

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Show more...
CEO
ISIN
US00791X2099

Listings

BOATS
BOATS
AEON.BOATS
XASE
US
AEON

0 Comments

Share your thoughts

FAQ

What is AEON Biopharma stock price today?▼
The current price of AEON.BOATS is $0.99 USD — it has increased by +2.07% in the past 24 hours. Watch AEON Biopharma stock price performance more closely on the chart.
What is AEON Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AEON Biopharma stocks are traded under the ticker AEON.BOATS.
What is AEON Biopharma market cap?▼
Today AEON Biopharma has the market capitalization of 11.66M
When is the next AEON Biopharma earnings date?▼
AEON Biopharma is going to release the next earnings report on May 20, 2026.
What is AEON Biopharma revenue for the last year?▼
AEON Biopharma revenue for the last year amounts to 0 USD.
What is AEON Biopharma net income for the last year?▼
AEON.BOATS net income for the last year is 84.01M USD.
When did AEON Biopharma complete a stock split?▼
AEON Biopharma has not had any recent stock splits.